APM

Aptorum Group Limited Class A Ordinary Shares

HealthcareBiotechnologyUnited KingdomNASDAQ

$0.85

-2.06%today

MKT CAP

$7M

-5.6% · 1Y

Full Financials

Trailing P/E-

Forward P/E-1.2x

EV/EBITDA-

Price/Sales-

Dividend Yield-

Revenue Growth YoY-

Earnings Growth YoY-

Revenue Growth QoQ-

5y Revenue CAGR+34.3%

5y Earnings CAGR-

Gross Margin-

Operating Margin-

Net Margin-

ROE-

Debt / Equity-

Free Cash Flow-

Insider Ownership16.4%

Institutional Ownership2.4%

Short % of Float0.20%

Days to Cover0.1d

1 Week-1.1%

1 Month-

3 Months-

6 Months-

YTD-

1 Year-

3 Years-

5 Years-

vs 50-day SMA-

vs 200-day SMA-

vs 52w High-

vs 52w Low-

Top Holders

Holder	Type	% Held	Value	Δ Shares	As of
Citadel Advisors Llc	institution	1.82%	$0.00B	+100.00%	2025-12-31
Fidelity Commonwealth Trust-Fidelity Nasdaq Composite Index ETF	fund	1.13%	$0.00B	+0.14%	2025-08-31
Two Sigma Investments, LP	institution	0.27%	$0.00B	+100.00%	2025-12-31
Morgan Stanley	institution	0.21%	$0.00B	+100.00%	2025-12-31
Osaic Holdings Inc.	institution	0.09%	$0.00B	+0.00%	2025-12-31
UBS Group AG	institution	0.03%	$0.00B	-27.50%	2026-03-31
BNP Paribas Financial Markets	institution	0.01%	$0.00B	+100.00%	2025-12-31
SBI Securities Co., Ltd.	institution	0.00%	$0.00B	+0.00%	2026-03-31

Peers

Ticker	Cap	Score	P/E	Fwd P/E	EV/EBITDA	ROE	Gross	D/E	Div
PTGX Protagonist Therapeutics Inc. Common Stock	$6.6B	5	-	-	-	-	-	-	0.00%
CELC Celcuity Inc. Common Stock	$6.7B	5	-	-	-	-	-	-	0.00%
ACLX Arcellx Inc. Common Stock	$6.7B	5	-	-	-	-	-	-	-
KYMR Kymera Therapeutics Inc. Common Stock	$7.0B	-	-	-	-	-27.1%	0%	5.23	0.00%
TECH Bio-Techne Corp Common Stock	$7.1B	36	72.7	24.4	-	-	-	-	63.00%
HALO Halozyme Therapeutics Inc. Common Stock	$7.9B	73	25.5	6.6	-	-	-	-	0.00%